skullcapflavone ii has been researched along with aristolochic acid i in 1 studies
| Studies (skullcapflavone ii) | Trials (skullcapflavone ii) | Recent Studies (post-2010) (skullcapflavone ii) | Studies (aristolochic acid i) | Trials (aristolochic acid i) | Recent Studies (post-2010) (aristolochic acid i) |
|---|---|---|---|---|---|
| 18 | 0 | 13 | 1,088 | 2 | 548 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Chen, SZ; Chen, XF; Dong, YP; Fan, ZC; Feng, F; Gu, YQ; He, HS; Jiang, LX; Sun, ZR; Wang, HY; Wen, W; Zhang, Y | 1 |
1 other study(ies) available for skullcapflavone ii and aristolochic acid i
| Article | Year |
|---|---|
Skullcapflavone II, a novel NQO1 inhibitor, alleviates aristolochic acid I-induced liver and kidney injury in mice.
Topics: Animals; Aristolochic Acids; Humans; Kidney; Liver; Mice; NAD(P)H Dehydrogenase (Quinone) | 2023 |